DOJ's Bureau of Prisons Orders $22.7K in Turalio Medication for FY26
Contract Overview
Contract Amount: $22,725 ($22.7K)
Contractor: Daiichi Sankyo, Inc
Awarding Agency: Department of Justice
Start Date: 2026-04-01
End Date: 2026-04-30
Contract Duration: 29 days
Daily Burn Rate: $784/day
Competition Type: FULL AND OPEN COMPETITION
Number of Offers Received: 1
Pricing Type: FIRM FIXED PRICE
Sector: Healthcare
Official Description: FY26 APR TURALIO DAIICHI PHARMACY/BIOLOGICS ORDER TURALIO 125MG, 120CT $22,725.09
Place of Performance
Location: BASKING RIDGE, SOMERSET County, NEW JERSEY, 07920
Plain-Language Summary
Department of Justice obligated $22,725.09 to DAIICHI SANKYO, INC for work described as: FY26 APR TURALIO DAIICHI PHARMACY/BIOLOGICS ORDER TURALIO 125MG, 120CT $22,725.09 Key points: 1. The Federal Prison System is procuring Turalio (125mg, 120ct) for $22,725.09. 2. This is a single delivery order under a larger contract. 3. The procurement falls under Pharmaceutical Preparation Manufacturing. 4. The contract type is Firm Fixed Price, indicating stable costs.
Value Assessment
Rating: good
The price of $22,725.09 for Turalio (125mg, 120ct) appears reasonable given the specialized nature of the drug and its typical high cost. Benchmarking against similar pharmaceutical contracts for specialty medications would provide further validation.
Cost Per Unit: $189.38 per bottle (120ct)
Competition Analysis
Competition Level: full-and-open
This procurement was conducted under full and open competition, suggesting that multiple vendors had the opportunity to bid. This competitive process generally leads to better price discovery and potentially more favorable pricing for the government.
Taxpayer Impact: The competitive nature of the award is positive for taxpayers, as it aims to secure the best possible price for essential medications.
Public Impact
Ensures access to critical medication for inmates within the Federal Prison System. Supports the health and well-being of the incarcerated population. Demonstrates the government's commitment to providing necessary medical treatments. The specific drug, Turalio, is used for treating tenosynovial giant cell tumor (TGCT).
Waste & Efficiency Indicators
Waste Risk Score: 78 / 10
Positive Signals
- Full and open competition utilized.
- Firm Fixed Price contract type.
- Specific delivery order for a defined quantity and period.
Sector Analysis
The pharmaceutical sector is characterized by high research and development costs, patent protections, and complex regulatory environments. Government spending in this area often involves significant investment in specialized medications to ensure public health and meet specific needs, such as inmate care.
Small Business Impact
Information regarding small business participation in this specific delivery order is not provided. However, the pharmaceutical manufacturing sector often involves large, established companies.
Oversight & Accountability
The Bureau of Prisons, under the Department of Justice, is responsible for this procurement. Standard oversight mechanisms for federal contracting, including contract performance monitoring and financial accountability, would apply.
Related Government Programs
- Pharmaceutical Preparation Manufacturing
- Department of Justice Contracting
- Federal Prison System / Bureau of Prisons Programs
Risk Flags
- Potential for supply chain disruptions for specialized medication.
- Reliance on a single manufacturer for a specific drug.
- Need for ongoing price benchmarking against other large purchasers.
Tags
pharmaceutical-preparation-manufacturing, department-of-justice, nj, delivery-order, under-100k
Frequently Asked Questions
What is this federal contract paying for?
Department of Justice awarded $22,725.09 to DAIICHI SANKYO, INC. FY26 APR TURALIO DAIICHI PHARMACY/BIOLOGICS ORDER TURALIO 125MG, 120CT $22,725.09
Who is the contractor on this award?
The obligated recipient is DAIICHI SANKYO, INC.
Which agency awarded this contract?
Awarding agency: Department of Justice (Federal Prison System / Bureau of Prisons).
What is the total obligated amount?
The obligated amount is $22,725.09.
What is the period of performance?
Start: 2026-04-01. End: 2026-04-30.
What is the total annual spending on Turalio by the Federal Prison System?
The provided data only reflects a single delivery order for FY26. To determine total annual spending, a comprehensive review of all contracts and orders for Turalio placed by the Bureau of Prisons and other federal agencies would be necessary. This would include examining historical data and future projections.
Are there any known supply chain risks associated with Turalio?
Turalio is a specialized medication, and like many pharmaceuticals, it could be subject to supply chain disruptions due to manufacturing issues, raw material shortages, or global demand fluctuations. The government should monitor the manufacturer's supply chain stability and consider contingency plans for alternative treatments if necessary.
How does the per-unit cost compare to Turalio purchased through the Veterans Health Administration or other large healthcare providers?
Benchmarking the per-unit cost of $189.38 against Turalio purchases by other major healthcare systems like the VA or large private insurers is crucial. Differences in volume, contract terms, and negotiation power can lead to price variations. A formal comparison would reveal if the Federal Prison System is achieving competitive pricing.
Industry Classification
NAICS: Manufacturing › Pharmaceutical and Medicine Manufacturing › Pharmaceutical Preparation Manufacturing
Product/Service Code: MEDICAL SERVICES › MEDICAL, DENTAL, AND SURGICAL SVCS
Competition & Pricing
Extent Competed: FULL AND OPEN COMPETITION
Solicitation Procedures: SUBJECT TO MULTIPLE AWARD FAIR OPPORTUNITY
Offers Received: 1
Pricing Type: FIRM FIXED PRICE (J)
Evaluated Preference: NONE
Contractor Details
Parent Company: Daiichi Sankyo Company, Limited
Address: 211 MT AIRY RD, BASKING RIDGE, NJ, 07920
Business Categories: Category Business, Corporate Entity Not Tax Exempt, Not Designated a Small Business, Special Designations, U.S.-Owned Business
Financial Breakdown
Contract Ceiling: $22,725
Exercised Options: $22,725
Current Obligation: $22,725
Contract Characteristics
Commercial Item: COMMERCIAL PRODUCTS/SERVICES
Parent Contract
Parent Award PIID: 36F79718D0403
IDV Type: FSS
Timeline
Start Date: 2026-04-01
Current End Date: 2026-04-30
Potential End Date: 2026-04-30 00:00:00
Last Modified: 2026-04-07
Other Department of Justice Contracts
- Contractor Owned and Operated Existing Correctional Facility for Approximately 3,500 LOW Security Male Inmates — $794.5M (Cornell Companies, Inc.)
- Detention Services - SAN Diego — $776.9M (THE GEO Group, Inc.)
- CO: Telly Renfroe Award of NEW Task Order Base Year Initial Funding — $616.4M (AT&T Enterprises, LLC)
- TAS 151060 - Services for the Management and Operation of a Contractor-Owned, Contractor-Operated, Correctional Facility for 2,567 Beds in Adams County, Mississippi — $574.3M (Corecivic, Inc.)
- Provide Services for the Management and Operation of a Correctional Facility in Accordance With Rfp-Pcc-0014 — $568.9M (Cornell Companies, Inc.)